Trial Profile
A Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2014
Price :
$35
*
At a glance
- Drugs Terbogrel (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 26 Aug 2014 New trial record